Phase 3 GUARD Trial of ADX-2191 (Methotrexate for Intravitreal Administration) to Prevent Proliferative Vitreoretinopathy and Other Postoperative Complications

  • Christina Joy Flaxel, MD
  • Video
  • Published 2023

See more